figshare
Browse
12916_2024_3329_MOESM1_ESM.docx (114.5 kB)

Additional file 1 of Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial

Download (114.5 kB)
journal contribution
posted on 2024-03-08, 06:01 authored by Yanfei Liu, Lingyan Ping, Yuqin Song, Yongjing Tang, Wen Zheng, Weiping Liu, Zhitao Ying, Chen Zhang, Meng Wu, Feier Feng, Ningjing Lin, Meifeng Tu, Jun Zhu, Yan Xie
Additional file 1. Study protocol.

History

Usage metrics

    BMC Medicine

    Categories

    Keywords

    Hodgkin diseaseCamrelizumabGemcitabineOxaliplatin

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC